References
Fink JK (2013) Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol 126:307–328
Chelban V, Lynch DS, Houlden H, Wood N (2016) Triple trouble: a striking new phenotype or competing genes in a family with hereditary spastic paraplegia. J Neurol 263:1232–1233
Kim SM et al (2009) Novel compound heterozygous mutations of the SPG11 gene in Korean families with hereditary spastic paraplegia with thin corpus callosum. J Neurol 256:1714–1718
Lossos A, Stevanin G, Meiner V et al (2006) Hereditary spastic paraplegia with thin corpus callosum: reduction of the SPG11 interval and evidence for further genetic heterogeneity. Arch Neurol 63:756–760
Riverol M, Samaranch L, Pascual B, Pastor P, Irigoyen J, Pastor MA, de Castro P, Masdeu JC (2009) Forceps minor region signal abnormality “ears of the lynx”: an early MRI finding in spastic paraparesis with thin corpus callosum and mutations in the spatacsin gene (SPG11) on chromosome 15. J Neuroimaging 19:52–60
Schüle R, Schlipf N, Synofzik M et al (2009) Frequency and phenotype of SPG11 and SPG15 in complicated hereditary spastic paraplegia. J Neurol Neurosurg Psychiatry 80:1402–1404
Hanein S, Martin E, Boukhris A, Byrne P, Goizet C, Hamri A et al (2008) Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal-recessive spastic paraplegia, including Kjellin syndrome. Am J Hum Genet 82:992–1002
Murmu RP, Martin E, Rastetter A et al (2011) Cellular distribution and subcellular localization of spatacsin and spastizin, two proteins involved in hereditary spastic paraplegia. Mol Cell Neurosci 47:191–202
Somasundaram S, Raghavendra S, Singh A, Kesavadas C, Nair M (2007) Hereditary spastic paraplegia with a thin corpus callosum. Pediatr Radiol 37:503–505
Raina S, Mokta JK, Sharma S (2009) Hereditary spastic paraplegia with thin corpus callosum. Ann Indian Acad Neurol. 12:56–57
Patel S, Sethi PK, Anand I, Batra A, Gupta P (2016) Hereditary spastic paraplegia with a thin corpus callosum due to SPG11 mutation. Neurol India. 64:171–172
Goizet C, Boukhris A, Maltete D et al (2009) SPG15 is the second most common cause of hereditary spastic paraplegia with thin corpus callosum. Neurology 14:1111–1119
Khundadze M, Kollmann K, Koch N, Biskup C, Nietzsche S, Zimmer G et al (2013) A hereditary spastic paraplegia mouse model supports a role of ZFYVE26/SPASTIZIN for the endolysosomal system. PLoS Genet 9:e1003988
Acknowledgments
We thank the patient and the parents for participating in this study. We thankfully acknowledge DST-FIST, Government of India, Manipal University and TIFAC Core for the infrastructure support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare no conflict of interest.
Ethical standard
This study followed ethical standards in conducting all diagnostic procedures. The patient was informed about the intention to publish the cases report and gave their written consent.
Rights and permissions
About this article
Cite this article
Chakrabarty, S., Vijayakumar, N., Radhakrishnan, K. et al. Spastizin mutation in hereditary spastic paraplegia with thin corpus callosum. J Neurol 263, 2130–2132 (2016). https://doi.org/10.1007/s00415-016-8258-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-016-8258-1